Skip to main content
logo
Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
35.62
+0.89 (2.56%)
Jun 30, 2026, 1:37 PM EDT - Market open

Roivant Sciences Revenue

In the fiscal year ending March 31, 2026, Roivant Sciences had annual revenue of $8.26M, down -71.57%. Roivant Sciences had revenue of $2.52M in the quarter ending March 31, 2026, a decrease of -66.71%.

Revenue (ttm)
$8.26M
Revenue Growth
-71.57%
P/S Ratio
3,114.81
Revenue / Employee
$11,456
Employees
721
Market Cap
25.62B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20268.26M-20.79M-71.57%
Mar 31, 202529.05M-3.66M-11.19%
Mar 31, 202432.71M-28.57M-46.62%
Mar 31, 202361.28M5.99M10.84%
Mar 31, 202255.29M31.49M132.34%
Mar 31, 202123.80M-43.89M-64.85%
Mar 31, 202067.69M65.37M2,812.61%
Mar 31, 20192.32M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BeOne Medicines AG5.70B
Incyte5.36B
Jazz Pharmaceuticals4.44B
Alnylam Pharmaceuticals4.29B
Genmab3.90B
BioNTech SE3.23B
Royalty Pharma2.44B
Moderna2.23B
Revenue Rankings

ROIV News

More News